Global 3D Cell Culture Market (2018-2023)

admin — Fri, 12 Apr 2019 02:37:55 +0000

Limitations of the two-dimensional (2D) cell culture models have led to the adoption of the three-dimensional (3D) cell culture in various biological research activities. Compared to the 2D methods, 3D cell culture allows cells to grow in a 3D surrounding that mimics the typical organ microarchitecture. In a 3D environment, cells tend to be exposed to better morphological and physiological changes, contrary to those grown in a 2D environment. Thus, the advantages offered by 3D cell culture in comparison to the 2D ones are key growth drivers for the market. The 3D cell culture market is expected to reach approximately USD 5.33 Bn by 2023, expanding at a compound annual growth rate (CAGR) of 29.2% during the 2018-2023 period.

Product type segment insights:

The scaffold-based 3D cell culture product segment is dominating the market and will continue to do so during the forecast period. This variant will occupy a market share of 36.6% among all the other product types by 2023. This high share is mainly attributed to the ability of scaffold-based products to impersonate in vivo conditions for the cell culture, thereby driving their adoption among researchers.

Application segment insights:

Depending on applications, the 3D cell culture market is segmented into drug discovery and toxicology, cancer research, and stem cell research/regenerative medicine. The cancer research sub-segment held the largest market share of about 42.8% in the year 2017. This is mainly attributed to the advantages offered by 3D cell culture over its 2D counterpart, growing number of cancer related researches, and funding initiatives across the globe. 3D cultures of cancer cells can generate new drug candidates for a researcher before moving to expensive and time-consuming animal models. 3D cell culture can speed discovery and save money involved in developing cancer models for preclinical screening and testing, as well as for the research and development (R&D) of new therapies.

End users segment insights:

3D cell culture is used across multiple end user segments, such as biotechnology and pharmaceutical companies, contract research laboratories, and academic institutes. Among these, the biotechnology and pharmaceutical companies dominated the market with a revenue of USD 0.77 Bn and 67% market share in 2017. This is primarily due to rising adoption of 3D cell culture as a new tool in early drug discovery, as well as potential treatment of diseases. Furthermore, rising need to continuously improve the productivity of pharmaceutical R&D is further accelerating implementation of 3D cell cultures in the early discovery of drugs.

Regional insights:

Based on regions, North America held the largest market share of about 41.8% of the global 3D cell culture market in the year 2017. This is because of a large number of ongoing research activities in this region, coupled with the availability of sufficient funding for research institutes to opt for relatively costlier technique such as 3D cell culture methods. The countries of the Asia-Pacific region will grow at the highest CAGR in the forecast period owing to rising number of contract research activities, growing focus of pharmaceutical and biotechnological companies on this region for their R&D activities, and increasing awareness among researchers about the benefits of 3D cell culture over 2D methods.

Companies covered:

1. Thermo Fisher Scientific
2. Corning Inc.
3. Lonza Group
4. Merck & Co.
5. InSphero AG
6. Hamilton
7. Kuraray
8. Emulate
9. Mimetas
10. Global Cell Solutions Inc.

Customizations available

The post Global 3D Cell Culture Market (2018-2023) first appeared on CRI Report.

Global 3D Cell Culture Market Research Report – Forecast to 2023

admin — Wed, 31 Oct 2018 08:56:07 +0000

The cell culture technique is present in biological areas for the development of drug discovery, regenerative medicine, and protein production. The cell culture technique has evolved from 2D cell culture to 3D cell culture. The 3D culture resembles physiological conditions closely and has various different advantages over the 2D culture conditions. The 3D cell culture can be defined as the culture of living cells within micro-assembled devices and supports the display of three-dimensional structures mimicking tissue and organ-specific microarchitecture.
The factors driving the market include increasing application of biotech and pharmaceutical companies and hospitals and rise in the patient population affected by cancer. The growing number of patients in need of organ transplantation is propelling the growth of the market. However, the high cost of devices, regulatory framework, and lack of awareness amongst the masses are major challenges for the market.
The global market for 3D cell culture is segmented on the basis of technique, product, application, end user, and region. On the basis type of technique, it is segmented into scaffold-based 3D cell culture and scaffold-free 3D cell culture. The scaffold-based 3D cell culture is further segmented into hydrogel-based support and polymeric hard material based support. The scaffold-free 3D cell culture is further segmented into hanging drop microplates, spheroid microplates containing ultra-low attachment (ULA) coating, and microfluidic 3D cell culture. On the basis of product, it is segmented into consumables and instruments. The consumables are further segmented into culture media, reagents, 3D multi-well plates, and glassware. The instruments are further segmented into bioreactor, flow cytometer, and cell culture chips. On the basis of application, it is segmented into drug discovery, cancer research, stem cell research, tissue screening and engineering, and regenerative medicine. On the basis of end users, it is segmented into pharmaceutical and biotechnology companies, contract research organizations, and research and academic laboratories.
The global 3D cell culture market accounted for USD 725.15 million in 2016 and is expected to register a CAGR of 25.50% over the forecast period.
Key Players
Thermo Fisher Scientific Inc., Lonza, Corning Incorporated, Kuraray Co Ltd, Becton, Dickinson and Company, Merck KGaA, Charles River Laboratories Inc., Tecan Trading AG, ReproCELL Europe Ltd, The Electrospinning Company, Lena Biosciences, Inc., InSphero, Global Cell Solutions Inc., Synthecon, Inc., and 3D Biotek LLC.
Study objectives
• To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global 3D cell culture market
• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global 3D cell culture market
• To provide a detailed analysis of the value chain and supply chain of the global 3D cell culture market

Target Audience
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Academic Institutes and Universities
• Potential Investors

Key Findings
• The global 3D cell culture market is expected to reach USD 3555.77 million by 2023 at a CAGR of 25.50 %
• On the basis of technique, the scaffold-based 3D cell culture is the largest segment which is projected to register a CAGR of 25.81% during the forecast period from 2017 to 2023
• On the basis of product, consumables are expected to account for the largest market share of 25.88% during the forecast period from 2017 to 2023
• On the basis of application, drug discovery is projected to register a CAGR of 25.75% during the forecast period from 2017 to 2023
• On the basis of end user, pharmaceutical and biotechnology companies captured the largest market globally and are expected to reach USD 1398.35 million by 2023
• On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas holds the largest share of the global 3D cell culture market which is expected to reach USD 1318.73 million by 2023
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 26.17% from 2017 to 2023
Regional Analysis
• Americas
o North America
 US
 Canada
o South America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

The post Global 3D Cell Culture Market Research Report – Forecast to 2023 first appeared on CRI Report.

3D Cell Culture – CRI Report

Global 3D Cell Culture Market (2018-2023)

Global 3D Cell Culture Market Research Report – Forecast to 2023